Papers
4
Total Citations
71
H-Index
4
About
Dr. Changrui Liu is a pioneering surgeon whose work centers on advancing minimally invasive techniques for thyroid cancer treatment, with a particular focus on robotic thyroidectomy and cervical lymph node dissection. His major contributions include refining the bilateral axillo-breast approach (BABA) for robotic lateral neck dissection, as demonstrated in his highly cited 2019 study of 260 cases—the largest single-center experience at the time—which established a safe, reproducible method for compartment-oriented lymph node clearance. Dr. Liu has also been instrumental in comparing emerging approaches: his 2022 comparative study of transoral-vestibular versus bilateral axillary-breast robotic thyroidectomy (27 citations) provided critical evidence on surgical outcomes, helping guide technique selection for papillary thyroid carcinoma patients. With over 70 total citations across his most influential works, his research directly impacts clinical decision-making in endocrine surgery. Notably, his 2024 comparison of transoral robotic thyroidectomy with traditional open surgery continues to shape the conversation around scarless neck surgery. Dr. Liu’s systematic evaluations of novel robotic platforms have positioned him as a key voice in the evolution of thyroid cancer surgery, balancing oncologic rigor with cosmetic and recovery benefits.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4